Risk of epileptic seizures higher in kids after COVID-19 infection than after influenza Dr. Kamal Kant Kohli19 Nov 2022 12:00 PM ISTChildren suffering from nonsevere COVID-19 infections are 55% more likely to develop epilepsy or seizures in the next 6 months than those who have...
Inclisiran safely reduces LDL-C in primary prevention patients with elevated levels: Study Medha Baranwal19 Nov 2022 11:45 AM ISTTwice-yearly maintenance dosing with inclisiran significantly reduces LDL-C and other atherogenic lipoprotein measurements in patients without...
Methylprednisolone does not reduce risk of worse outcomes in infants undergoing heart surgery: STRESS trial Medha Baranwal19 Nov 2022 11:30 AM ISTUSA: Perioperative administration of methylprednisolone for reduction of inflammation in infants undergoing surgery with cardiopulmonary bypass did...
Tzield, first drug to delay type 1 diabetes onset, receives FDA approval Medha Baranwal19 Nov 2022 11:15 AM ISTTZIELD is the first disease-modifying therapy for type 1 diabetes, a life-threatening autoimmune disease.USA: Tzield (teplizumab-mzwv), an injection...
Studies provide latest 'real world' evidence on effectiveness of covid-19 treatments Dr. Nandita Mohan19 Nov 2022 10:30 AM ISTThe debate around the effectiveness of COVID-19 treatments has been ongoing and often appears never-endingTwo studies published by The BMJ today...
Monocyte distribution width may help in early diagnosis of sepsis Jacinthlyn Sylvia19 Nov 2022 7:15 AM ISTA new study published in BMC Infectious Diseases suggests that with little additional work on the routine practices used during emergency treatment,...
Tolvaptan use tied to changes in mineral metabolism parameters and increased BMD in polycystic kidney disease Medha Baranwal18 Nov 2022 8:00 PM ISTSwitzerland: Chronic treatment with Tolvaptan is tied to an increased femoral bone mineral density (BMD), and remarkable changes in both acid-base...
Lipid treatment intervention as early as 17 years of age may reverse atherosclerosis progression Dr. Kamal Kant Kohli18 Nov 2022 11:15 AM ISTIt is well known that abnormal blood cholesterol and triglyceride levels known as elevated lipids and dyslipidemia are major causes of atherosclerosis...
FDA panel okays tenapanor as monotherapy for control of serum phosphorus in CKD patients on dialysis Dr. Kamal Kant Kohli18 Nov 2022 10:15 AM ISTUse of tenapanor (Xphozah®) as monotherapy for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis has...
Finerenone prevents progression of non-proliferative diabetic retinopathy: Study Medha Baranwal18 Nov 2022 9:15 AM ISTDenmark: A recent study in Diabetes, Obesity and Metabolism has reported the potential benefit of finerenone for delaying the progression of...
Cannabis not made safer by increasing its CBD content Dr. Nandita Mohan18 Nov 2022 9:15 AM ISTCannabis nowadays is widely used for recreational and medicinal drugs. New research from the Institute of Psychiatry, Psychology & Neuroscience...
Simvastatin could be new treatment option for patients with non-segmental vitiligo and dyslipidemia: Study Medha Baranwal17 Nov 2022 8:00 PM ISTEgypt: For patients with nonsegmental vitiligo (NSV) and dyslipidemia, a daily regimen of simvastatin 80 mg could be a helpful treatment, is the...
